Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives

by Luisa Carbognin, Federica Miglietta, Ida Paris, Maria Vittoria Dieci
Published 2019-09-01

Spectrum of Germline <i>BRCA1 </i>and<i> BRCA2</i> Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome

by Concetta Santonocito, Roberta Rizza, Ida Paris, Laura De Marchis, Carmela Paolillo, Giordana Tiberi, Giovanni Scambia, Ettore Capoluongo
Published 2020-05-01

Oligometastatic Breast Cancer: How to Manage It?

by Vittoria Barberi, Antonella Pietragalla, Gianluca Franceschini, Fabio Marazzi, Ida Paris, Francesco Cognetti, Riccardo Masetti, Giovanni Scambia, Alessandra Fabi
Published 2021-06-01

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial

by Francesco Schettini, Francesco Schettini, Silvia Paola Corona, Silvia Paola Corona, Fabiola Giudici, Fabiola Giudici, Carla Strina, Marianna Sirico, Ottavia Bernocchi, Ottavia Bernocchi, Manuela Milani, Nicoletta Ziglioli, Sergio Aguggini, Carlo Azzini, Giuseppina Barbieri, Valeria Cervoni, Maria Rosa Cappelletti, Alfredo Molteni, Maria Chiara Lazzari, Giuseppina Ferrero, Marco Ungari, Elena Marasco, Alice Bruson, Luciano Xumerle, Elisa Zago, Davide Cerra, Marco Loddo, Gareth H. Williams, Ida Paris, Ida Paris, Giovanni Scambia, Giovanni Scambia, Daniele Generali, Daniele Generali
Published 2021-06-01

Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis

by Alessia Romito, Sonia Bove, Ilaria Romito, Drieda Zace, Ivano Raimondo, Simona Maria Fragomeni, Pierluigi Maria Rinaldi, Domenico Pagliara, Antonella Lai, Fabio Marazzi, Claudia Marchetti, Ida Paris, Gianluca Franceschini, Riccardo Masetti, Giovanni Scambia, Alessandra Fabi, Giorgia Garganese
Published 2021-07-01

Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II...

by Roberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, Rosalba Torrisi, Ida Paris, Monica Giordano, Vincenzo Montesarchio, Valentina Guarneri, Laura Amaducci, Domenico Bilancia, Giuseppina Cilenti, Alessandra Fabi, Elena Collovà, Alessio Schirone, Erminio Bonizzoni, Luigi Celio, Sabino De Placido, Michelino De Laurentiis
Published 2020-03-01

Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes

by Alba Di Leone, Daniela Terribile, Stefano Magno, Alejandro Martin Sanchez, Lorenzo Scardina, Elena Jane Mason, Sabatino D’Archi, Claudia Maggiore, Cristina Rossi, Annalisa Di Micco, Stefania Carnevale, Ida Paris, Fabio Marazzi, Valeria Masiello, Armando Orlandi, Antonella Palazzo, Alessandra Fabi, Riccardo Masetti, Gianluca Franceschini
Published 2021-04-01

CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Persp...

by Michela Roberto, Antonio Astone, Andrea Botticelli, Luisa Carbognin, Alessandra Cassano, Giuliana D’Auria, Agnese Fabbri, Alessandra Fabi, Teresa Gamucci, Eriseld Krasniqi, Mauro Minelli, Armando Orlandi, Francesco Pantano, Ida Paris, Laura Pizzuti, Ilaria Portarena, Nello Salesi, Simone Scagnoli, Paola Scavina, Giuseppe Tonini, Patrizia Vici, Paolo Marchetti
Published 2021-01-01

Development of a Digital Research Assistant for the Management of Patients’ Enrollment in Oncology Clinical Trials within a Research Hospital

by Alfredo Cesario, Irene Simone, Ida Paris, Luca Boldrini, Armando Orlandi, Gianluca Franceschini, Filippo Lococo, Emilio Bria, Stefano Magno, Antonino Mulè, Angela Santoro, Andrea Damiani, Daniele Bianchi, Daniele Picchi, Guido Rasi, Gennaro Daniele, Alessandra Fabi, Paolo Sergi, Giampaolo Tortora, Riccardo Masetti, Vincenzo Valentini, Marika D’Oria, Giovanni Scambia
Published 2021-03-01

Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis o...

by Armando Orlandi, Elena Iattoni, Laura Pizzuti, Agnese Fabbri, Andrea Botticelli, Carmela Di Dio, Antonella Palazzo, Giovanna Garufi, Giulia Indellicati, Daniele Alesini, Luisa Carbognin, Ida Paris, Angela Vaccaro, Luca Moscetti, Alessandra Fabi, Valentina Magri, Giuseppe Naso, Alessandra Cassano, Patrizia Vici, Diana Giannarelli, Gianluca Franceschini, Paolo Marchetti, Emilio Bria, Giampaolo Tortora
Published 2020-12-01

Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

by Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lüftner, Sylvie Rottey, Peter A. van Dam, Khalil Zaman, Giorgio Mustacchi, Joseph Gligorov, Ahmad Awada, Mario Campone, Hans Wildiers, Alessandra Gennari, Vivianne C. G. Tjan-Heijnen, Javier Cortes, Mariavittoria Locci, Ida Paris, Lucia Del Mastro, Sabino De Placido, Miguel Martín, Guy Jerusalem, Sergio Venturini, Giuseppe Curigliano, Daniele Generali
Published 2021-09-01

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

by Giulia Bon, Laura Pizzuti, Valentina Laquintana, Rossella Loria, Manuela Porru, Caterina Marchiò, Eriseld Krasniqi, Maddalena Barba, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Giacomo Barchiesi, Marco Mazzotta, Daniele Marinelli, Silverio Tomao, Paolo Marchetti, Maria Rosaria Valerio, Rosanna Mirabelli, Antonio Russo, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Francesco Giotta, Carlo Garufi, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Giuseppe Sanguineti, Isabella Sperduti, Anna Sapino, Ruggero De Maria, Carlo Leonetti, Angelo Di Leo, Gennaro Ciliberto, Rita Falcioni, Patrizia Vici
Published 2020-12-01

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

by Laura Pizzuti, Maddalena Barba, Marco Mazzotta, Eriseld Krasniqi, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Domenico Sergi, Daniele Marinelli, Giancarlo Paoletti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Nicola Tinari, Antonino Grassadonia, Maria Rosaria Valerio, Rosanna Mirabelli, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Icro Meattini, Mirco Pistelli, Francesco Giotta, Vito Lorusso, Carlo Garufi, Antonio Russo, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Angela Vaccaro, Letizia Perracchio, Anna di Benedetto, Theodora Daralioti, Isabella Sperduti, Ruggero De Maria, Angelo Di Leo, Giuseppe Sanguineti, Gennaro Ciliberto, Patrizia Vici
Published 2021-07-01